Immunotechnology

Therapeutic immunization against cancer antigens using genetically engineered cells
pp. 161-172(12)
Authors: Skolin I.; Axelsson K.; Ghannad P.; Hernell O.; Wahlin Y.B.; Sjogren H.O.

A TNF receptor antagonistic scFv, which is not secreted in mammalian cells, is expressed as a soluble mono- and bivalent scFv derivative in insect cells
pp. 173-184(12)
Authors: Martins C.; Fonseca I.; Roque L.; Soares J.; Brocks B.; Rode H.-J.; Klein M.; Gerlach E.; Dubel S.; Little M.; Pfizenmaier K.; Moosmayer D.

Displaying human interleukin-2 on the surface of bacteriophage
pp. 185-193(9)
Authors: Dahllof G.; B&unknown;9gesund M.; Remberger M.; Ringden O.; Vispo N.S.; Callejo M.; Ojalvo A.G.; Santos A.; Chinea G.; Gavilondo J.V.; Arana M.J.

Evaluation of different lymphoid tissue sources for the construction of human immunoglobulin gene libraries
pp. 195-203(9)
Authors: Yip Y.L.; Hawkins N.J.; Clark M.A.; Ward R.L.

Optimization of scFv antibody production in transgenic plants
pp. 205-216(12)
Authors: Ficarra G.; Prignano F.; Romagnoli P.; Fiedler U.; Phillips J.; Artsaenko O.; Conrad U.

Regulation and expression of human Fabs under the control of the Escherichia coli arabinose promoter, P_BAD
pp. 217-226(10)
Authors: Tradati N.; Grigolat R.; Calabrese L.; Costa L.; Giugliano G.; Morelli F.; Scully C.; Boyle P.; Chiesa F.; Clark M.A.; Hammond F.R.; Papaioannou A.; Hawkins N.J.; Ward R.L.

Recent advances in phage display: the report of the Phage Club first meeting
pp. 227-231(5)
Author: Bradbury A.